John W. Kozarich
Director at Ligand Pharmaceuticals. Based in Palm Beach Gardens, Florida.
- Rank
- 7621st of 14,644
- Companies held
- 1
- Largest holding
- LGND, 100.0% of total
- Latest SEC filing
- Nov 12, 2026
What the $12.1M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Ligand Pharmaceuticals LGND Common Stock | Directly | 42,122 | $286.94 | $12.1M | 100.0% | Form 4, Nov 12, 2026 |
Share counts are the amounts John W. Kozarich reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | Sold | LGND | 500 | $325.00 | $163K | View |
| May 13, 2026 | Sold | LGND | 1,575 | $223.50 | $352K | View |
| May 12, 2026 | Sold | LGND | 459 | $224.00 | $103K | View |
| May 1, 2026 | Sold | LGND | 1 | $229.87 | $230 | View |
| May 1, 2026 | Sold | LGND | 165 | $231.87 | $38K | View |
| May 1, 2026 | Sold | LGND | 105 | $232.57 | $24K | View |
| May 1, 2026 | Sold | LGND | 116 | $234.09 | $27K | View |
| May 1, 2026 | Sold | LGND | 80 | $227.37 | $18K | View |
| Apr 1, 2026 | Sold | LGND | 43 | $202.91 | $9K | View |
| Apr 1, 2026 | Sold | LGND | 79 | $202.42 | $16K | View |
| Apr 1, 2026 | Sold | LGND | 40 | $201.24 | $8K | View |
| Apr 1, 2026 | Sold | LGND | 146 | $199.97 | $29K | View |
| Apr 1, 2026 | Sold | LGND | 159 | $204.26 | $32K | View |
| Mar 2, 2026 | Sold | LGND | 42 | $203.57 | $9K | View |
| Mar 2, 2026 | Sold | LGND | 50 | $202.54 | $10K | View |
| Mar 2, 2026 | Sold | LGND | 83 | $201.65 | $17K | View |
| Mar 2, 2026 | Sold | LGND | 204 | $199.69 | $41K | View |
| Mar 2, 2026 | Sold | LGND | 47 | $197.14 | $9K | View |
| Mar 2, 2026 | Sold | LGND | 41 | $200.40 | $8K | View |
| Feb 2, 2026 | Sold | LGND | 23 | $195.61 | $4K | View |
| Feb 2, 2026 | Sold | LGND | 23 | $197.20 | $5K | View |
| Feb 2, 2026 | Sold | LGND | 381 | $196.36 | $75K | View |
| Feb 2, 2026 | Sold | LGND | 39 | $191.00 | $7K | View |
| Feb 2, 2026 | Sold | LGND | 1 | $192.18 | $192 | View |
| Jan 2, 2026 | Sold | LGND | 21 | $186.59 | $4K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 7618 | Brian Lillie Director, Lumentum Holdings. San Jose, CA | $12.1M |
| 7619 | Connor Thomas L. O. Senior Vice President, PBF Energy. Parsippany, NJ | $12.1M |
| 7620 | Paulett Eberhart Director, Valero Energy. San Diego, CA | $12.1M |
| 7621 | John W. Kozarich Director, Ligand Pharmaceuticals. Palm Beach Gardens, FL | $12.1M |
| 7622 | Jolen Anderson Senior Exec VP, The Bank of New York Mellon. New York, NY | $12.1M |
| 7623 | Steven J. Fasching Chief Financial Officer, Deckers Outdoor. Goleta, CA | $12.1M |
| 7624 | Christopher Ripley President & CEO, Sinclair. Cockeysville, MD | $12.1M |
Other Ligand Pharmaceuticals insiders
All LGND insiders- John L. Higgins$120MDirector. #1162 overall
- Matthew W. Foehr$74.6MInsider. #1498 overall
- Todd C. Davis$57.2MChief Executive Officer. #1695 overall
- Jason Aryeh$31.7MDirector. #3493 overall
- Matthew E. Korenberg$14.6MPresident & COO. #6393 overall
- Sunil Patel$13.3MInsider. #6658 overall
Questions
How much stock does John W. Kozarich own?
John W. Kozarich holds $12,086,487 in listed stock based on SEC filings and current prices, mostly Ligand Pharmaceuticals (LGND). That ranks 7621st on the Stock Rich List.
Is this John W. Kozarich's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did John W. Kozarich last buy or sell stock?
The most recent open-market trade on file is a sale of 500 LGND shares on Nov 12, 2026 at $325.00.